понедельник, 14 марта 2016 г.

Novo Nordisk - Saxenda Provides Added Value That The Market May Not Appreciate

Novo Nordisk - Saxenda Provides Added Value That The Market May Not Appreciate


Novo Nordisk has secret weapons of sorts when it comes to entering the anti-obesity space. The first secret weapon is that the main ingredient in the anti-obesity drug Saxenda is the same ingredient, liraglutide, in the already successful diabetes drug Victoza.



from Biotech News